BeStock  
Stocks › Biotechnology › INSM

Insmed INSM

US equityMarket cap rank #511Biotechnology
$110.61 −$3.53 (-3.09%)
Market open · Oct 1, 11:50 am ET · After hours $115.68 +1.35%
Open$114.51
Prev close$114.14
Day range$109.71 – $116.18
Volume708.2K
Market cap$24.16B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$425.49M+296.1% YoY
Operating profit-$101.31M+60.1% YoY
Net profit-$13.24M+95.9% YoY
Diluted EPS-$0.06+96.5% YoY
Free cash flow-$95.09M+54.5% YoY
Operating cash flow-$88.83M

Revenue, last 8 quarters

$93.4MSep '24$104.4MDec '24$92.8MMar '25$107.4MJun '25$142.3MSep '25$263.8MDec '25$306.0MMar '26$425.5MJun '26

Net profit, last 8 quarters

$-220.5MSep '24$-235.5MDec '24$-256.6MMar '25$-321.7MJun '25$-370.0MSep '25$-328.5MDec '25$-163.6MMar '26$-13.2MJun '26

Diluted EPS by quarter

-1.27Sep '24-1.32Dec '24-1.42Mar '25-1.70Jun '25-1.75Sep '25-1.54Dec '25-0.76Mar '26-0.06Jun '26

Free cash flow by quarter

$-184.6MSep '24$-202.8MDec '24$-272.2MMar '25$-209.1MJun '25$-222.2MSep '25$-264.2MDec '25$-226.2MMar '26$-95.1MJun '26

Annual revenue

$164.4MFY20$188.5MFY21$245.4MFY22$305.2MFY23$363.7MFY24$606.4MFY25

Profitability & balance sheet

Gross margin83.5%
Operating margin-71.4%
Net margin-76.9%
Return on equity-87.2%
Return on assets-38.2%
Return on invested capital-52.5%
Current ratio3.72
Liabilities / assets64.0%
Cash & investments$1.16B
Total debt$570.07M
Net cash (debt)$590.25M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $425.49M $305.96M $606.42M $263.84M $142.34M
Total Operating Revenue $425.49M $305.96M $606.42M $263.84M $142.34M
Cost of Revenue $67.21M $47.42M $122.94M $44.22M $29.37M
Gross Profit $358.27M $258.54M $483.49M $219.62M $112.98M
Operating Expense $459.58M $458.83M $1.48B $469.33M $374.33M
Selling and Admin Expenses $247.47M $247.26M $701.17M $212.48M $186.38M
-General & Admin Expense $247.47M $247.26M $701.17M $212.48M $186.38M
Research & Development $210.03M $209.49M $771.09M $254.91M $186.42M
Depreciation & Amortization & Depletion $2.08M $2.08M $6.00M $1.94M $1.54M
-Depreciation & Amortization $2.08M $2.08M $6.00M $1.94M $1.54M
Operating Profit -$101.31M -$200.28M -$994.78M -$249.71M -$261.35M
Net Non-Operating Interest Income (Expense) -$20.27M -$20.08M -$83.80M -$20.60M -$20.38M
Non-Operating Interest Expense $18.84M $18.70M $77.58M $19.22M $19.04M
Total Other Finance Costs $1.43M $1.38M $6.22M $1.38M $1.34M
Other Income (Expense) $110.21M $58.27M -$193.18M -$56.63M -$86.97M
Gain on Sale of Security $10.98M $12.04M $60.66M $15.24M $18.29M
Special Income (Charges) $99.76M $46.96M -$251.99M -$70.04M -$104.65M
-Less:Restructuring and Mergern & Acquisition -$99.76M -$46.96M $251.99M $70.04M $104.65M
Other Non-Operating Income (Expenses) -$531,000.00 -$736,000.00 -$1.84M -$1.82M -$603,000.00
Pretax Profit -$11.37M -$162.10M -$1.27B -$326.93M -$368.70M
Tax $1.87M $1.47M $5.03M $1.55M $1.32M
Net Profit -$13.24M -$163.56M -$1.28B -$328.49M -$370.02M
Profit from Continuing Operations -$13.24M -$163.56M -$1.28B -$328.49M -$370.02M
Net Income to Parent Company -$13.24M -$163.56M -$1.28B -$328.49M -$370.02M
Net Income to Common Stockholders -$13.24M -$163.56M -$1.28B -$328.49M -$370.02M
Basic EPS -$0.06 -$0.76 -$6.42 -$1.54 -$1.75
Diluted EPS -$0.06 -$0.76 -$6.42 -$1.54 -$1.75
Non-Operating Interest Income – – $0.00 $0.00 $0.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $2.10B $2.08B $2.26B $2.26B $2.36B
Total Current Assets $1.63B $1.61B $1.79B $1.79B $1.93B
Cash and Cash Equivalents & Short-Term Investments $1.16B $1.22B $1.43B $1.43B $1.68B
-Cash and Cash Equivalents $544.77M $582.19M $510.45M $510.45M $334.76M
-Short Term Investments $615.55M $641.33M $919.60M $919.60M $1.35B
Receivables $215.33M $178.56M $140.86M $140.86M $65.26M
-Accounts Receivable $215.33M $178.56M $140.86M $140.86M $65.26M
Inventory $142.38M $132.91M $132.07M $132.07M $120.97M
Other Current Assets $115.90M $78.20M $91.24M $91.24M $65.60M
Total Non-Current Assets $468.65M $462.69M $470.35M $470.35M $428.93M
Net PPE $134.60M $131.73M $139.21M $139.21M $116.62M
-Gross PPE $201.30M $195.33M $199.97M $199.97M $173.81M
-Accumulated Depreciation -$66.70M -$63.59M -$60.76M -$60.76M -$57.20M
Goodwill and Other Intangible Assets $229.60M $231.68M $233.76M $233.76M $220.70M
-Goodwill $136.11M $136.11M $136.11M $136.11M $136.11M
-Other Intangible Assets $93.49M $95.57M $97.65M $97.65M $84.59M
Other Non-Current Assets $104.44M $99.28M $97.38M $97.38M $91.61M
Total Liabilities $1.35B $1.37B $1.53B $1.53B $1.42B
Total Current Liabilities $438.74M $361.01M $468.87M $468.87M $417.21M
Payables $128.94M $102.64M $103.46M $103.46M $93.90M
-Accounts Payable $74.56M $73.38M $79.91M $79.91M $79.59M
-Other Payable $54.39M $29.26M $23.55M $23.55M $14.31M
Current Accrued Expenses $238.41M $203.93M $241.09M $241.09M $203.72M
Short-Term Debt and Capital Lease Obligation $9.82M $8.45M $12.81M $12.81M $7.38M
-Current Capital Lease Obligation $9.82M $8.45M $12.81M $12.81M $7.38M
Total Non-Current Liabilities $906.33M $1.01B $1.06B $1.06B $997.95M
Long Term Debt and Capital Lease Obligation $570.07M $571.87M $573.86M $573.86M $568.90M
-Long Term Debt $543.51M $542.22M $540.96M $540.96M $539.72M
-Long Term Capital Lease Obligation $26.55M $29.66M $32.89M $32.89M $29.18M
Other Non-Current Liabilities $336.26M $438.13M $482.85M $482.85M $429.05M
Total Equity $757.49M $704.85M $738.98M $738.98M $945.57M
Stockholders' Equity $757.49M $704.85M $738.98M $738.98M $945.57M
Capital Stock $2.18M $2.17M $2.14M $2.14M $2.13M
-Common Stock $2.18M $2.17M $2.14M $2.14M $2.13M
Additional Paid-In Capital $6.57B $6.50B $6.37B $6.37B $6.25B
Retained Earnings -$5.81B -$5.80B -$5.64B -$5.64B -$5.31B
Gains/Losses Not Affecting Retained Earnings -$3.37M $4,000.00 $1.46M $1.46M $2.00M
Current Deferred Liabilities – – – – $42.50M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$88.83M -$222.74M -$935.01M -$247.60M -$219.76M
Net cash flow from continuing operations -$88.83M -$222.74M -$935.01M -$247.60M -$219.76M
Net Income from Continuing Operations -$13.24M -$163.56M -$1.28B -$328.49M -$370.02M
Depreciation & Depletion & Amortization $5.26M $5.02M $16.45M $5.56M $4.00M
Other Non-Cash Items -$91.71M -$39.22M $291.25M $84.33M $112.98M
Change in Working Capital -$24.93M -$64.21M -$80.30M -$37.64M $13.90M
-Change in Receivables -$37.16M -$38.19M -$88.31M -$77.30M -$10.23M
-Change in Inventory -$12.97M -$1.89M -$31.52M -$11.76M -$13.76M
-Change in Prepaid Assets -$37.64M $12.59M -$53.43M -$26.22M -$3.73M
-Change in Payables and Accrued Expense $68.82M -$33.88M $100.07M $90.35M $45.56M
-Change in Other Current Assets -$5.23M -$2.36M -$2.12M -$11.79M -$2.85M
-Change in Other Current Liabilities -$744,000.00 -$497,000.00 -$4.99M -$914,000.00 -$1.10M
Net cash flow from investing $24.51M $265.52M -$64.58M $389.41M -$762.23M
Net Cash Flow from Continuing Investing Activities $24.51M $265.52M -$64.58M $389.41M -$762.23M
Net PPE Purchase and Sale -$6.26M -$3.48M -$32.56M -$16.59M -$2.42M
Net Investment Purchase and Sale $30.77M $284.00M -$2.01M $436.00M -$759.82M
Net Other Investing Changes $0.00 -$15.00M -$30.00M – –
Financing Cash Flow $27.18M $29.51M $954.07M $33.86M $33.41M
Net Cash Flow from Continuing Financing Activities $27.18M $29.51M $954.07M $33.86M $33.41M
Net Issuance Payments Of Debt -$827,000.00 -$799,000.00 -$4.93M -$776,000.00 -$747,000.00
Proceeds from Stock Option Exercised $28.01M $30.31M $135.72M $34.64M $34.41M
Ending Cash Balance $544.77M $582.19M $510.45M $510.45M $334.76M
Net Change in Cash -$37.14M $72.30M -$45.52M $175.67M -$948.58M
Beginning Cash Balance $582.19M $510.45M $555.03M $334.76M $1.28B
Effect of Exchange Rate Changes -$287,000.00 -$553,000.00 $931,000.00 $7,000.00 -$976,000.00
Free Cash Flow -$95.09M -$226.22M -$967.58M -$264.19M -$222.18M
Net Common Stock Issuance – – $823.28M $0.00 -$256,000.00

Discussion

No comments yet — be the first to weigh in on INSM.

Leave a comment

Scroll to Top